"Aaron brings a high-level of bio-process and manufacturing expertise that are essential to NewLeaf as we expand our Terrasym portfolio. We are bringing more options to our customers insuring larger, more sustainable yield at harvest," says Desmond Jimenez, Vice President of Product Development.
Kelley earned his Ph.D. in Chemical Engineering from the University of Minnesota and has experience in discerning customer needs and a proven track record scaling and launching biotechnology, agricultural, food ingredient, and animal nutrition products.
"What attracted me to NewLeaf was the caliber of its management, its singular focus on M-trophs, and the incredible depth of knowledge in the company. I look forward to building the team's competency to further scale the manufacturing process to meet growing customer demand," Kelley said.
NewLeaf's Terrasym™ technology brings a new class of agricultural biologicals to the market. Terrasym 401 for soybeans and Terrasym 402 for peanuts have been launched in the US in 2018.
About NewLeaf Symbiotics
NewLeaf Symbiotics is an agricultural biologicals company engaged in discovery, development, production, and commercialization of products containing beneficial plant microbes. Located in the heart of the plant science corridor, adjacent to the Danforth Plant Science Center in St. Louis, its 40+member team includes 12 Ph.D. scientists. The company has filed over 75 patents, has 15 products in its pipeline, and in 2018 introduced its first two products in the US, Terrasym 401 for soybeans and Terrasym 402 for peanuts. Visit NewLeaf Symbiotics at www.newleafsym.com.
SOURCE NewLeaf Symbiotics
Related Links
http://www.newleafsym.com
Share this article